Extensive Investment in Developing Novel Products Stimulating Growth Opportunities in the Global CKD Drugs Market 2015-2019

​Reportstack has announced a new market research report on the Global Chronic Kidney Disease (CKD) Drugs Market 2015-2019. Approval of new pipelines drugs is one of the key trends being witnessed in this market. The approval of new products gives motivation to the market players and directs their focus toward R&D and innovation. The launch of three new pipeline drugs, ferric citrate, Omontys (peginesatide), and Nulojix (belatacept), is expected to boost the market. The Global CKD Drugs market is expected to grow at a CAGR of 1.21 percent during the forecast period of 2014-2019.

To access full report with TOC, please visit Global Chronic Kidney Disease (CKD) Drugs Market 2015-2019

The upsurge in prevalence of CKD across the globe has given an opportunity for the CKD drug manufacturers. The steady growth in the market is a result of a rise in diagnostic centers and advances in therapeutics. “Major pharmaceutical companies in the nephrology therapeutic domain are investing heavily in R&D to develop new drugs for CKD,” 

“For instance, in 2014 OPKO Health developed effective marketing strategies for new drugs to treat CKD. This is an important milestone for the company in Renal Division for development and launch of proprietary products.”

To define the market conditions in the next 3-4 years, The analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.

About Reportstack:

Reportstackis one of the leading distributors of market research reports in the world today. We host more than 200,000 research products from the world's top publication houses. These publications are distributed amongst 12 top industry verticals and 62 sub verticals, which are then further classified into 257 business categories and 5000 micro markets. The vast selection criterion provides granular data from the length and breadth of all these industries delivering Reportstack members with cutting edge research products to facilitate strategic business decisions.


Debora White
Manager - Marketing
Ph: +1-888-789-6604
Reportstack Market Research